Skip to content
10-Q

Quarterly Report

BEONE MEDICINES LTD. BEIGF ONC

0001628280-26-030867

← back to feed
Filed
May 6, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 30, 2026 1.45B sh
Shares Diluted Q1 2026 · Mar 31, 2026 1.51B sh
Shares Diluted Q1 2026 · Mar 31, 2025 1.45B sh
Capex Q1 2026 · Mar 31, 2026 $40.79M
Capex Q1 2026 · Mar 31, 2025 $56.41M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $201.34M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $44.08M
Long Term Debt Q1 2026 · Mar 31, 2026 $962.52M
Long Term Debt Q1 2026 · Dec 31, 2025 $961.91M
Short Term Debt Q1 2026 · Mar 31, 2026 $9.26M
Short Term Debt Q1 2026 · Dec 31, 2025 $9.06M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $4.79B
Cash And Equivalents Q1 2026 · Dec 31, 2025 $4.55B
Cash And Equivalents Q1 2026 · Mar 31, 2025 $2.52B
Stockholders Equity Q1 2026 · Mar 31, 2026 $4.76B
Stockholders Equity Q1 2026 · Dec 31, 2025 $4.36B
Stockholders Equity Q1 2026 · Mar 31, 2025 $3.5B
Stockholders Equity Q1 2026 · Dec 31, 2024 $3.33B
Current Liabilities Q1 2026 · Mar 31, 2026 $1.81B
Current Liabilities Q1 2026 · Dec 31, 2025 $1.83B
Total Liabilities Q1 2026 · Mar 31, 2026 $3.79B
Total Liabilities Q1 2026 · Dec 31, 2025 $3.83B
Current Assets Q1 2026 · Mar 31, 2026 $6.6B
Current Assets Q1 2026 · Dec 31, 2025 $6.23B
Total Assets Q1 2026 · Mar 31, 2026 $8.55B
Total Assets Q1 2026 · Dec 31, 2025 $8.19B
Eps Diluted Q1 2026 · Mar 31, 2026 $0.15
Eps Diluted Q1 2026 · Mar 31, 2025 $0.00
Eps Basic Q1 2026 · Mar 31, 2026 $0.16
Eps Basic Q1 2026 · Mar 31, 2025 $0.00
Sga Expense Q1 2026 · Mar 31, 2026 $555.1M
Sga Expense Q1 2026 · Mar 31, 2025 $459.29M
Rd Expense Q1 2026 · Mar 31, 2026 $541.22M
Rd Expense Q1 2026 · Mar 31, 2025 $481.89M
Net Income Q1 2026 · Mar 31, 2026 $227.36M
Net Income Q1 2026 · Mar 31, 2025 $1.27M
Operating Income Q1 2026 · Mar 31, 2026 $249.9M
Operating Income Q1 2026 · Mar 31, 2025 $11.1M
Gross Profit Q1 2026 · Mar 31, 2026 $1.35B
Gross Profit Q1 2026 · Mar 31, 2025 $952.28M
Revenue Q1 2026 · Mar 31, 2026 $1.51B
Revenue Q1 2026 · Mar 31, 2025 $1.12B